Please feel free to forward to your colleagues and share the news of our journal | Dear Colleague, We are delighted to announce the publication of Volume 7, Issue 1 of Bladder Cancer (BLC). This issue hosts an outstanding selection of content, including one review article and nine research articles. From the editors of the regular journal sections, there are also new Challenging Case, Clinical Trials Corner, and Paper Alert contributions. The full issue is freely available online and can be browsed in full below. In this mailing, we are also pleased to announce that Editorial Board member Andrea Apolo has been promoted to become Associate Editor for Reviews, alongside Georgios Gakis and Nathan Lawrentschuk. Read more in the news section below. The previous editor Matt Galsky steps down and we thank him for his many contributions to the journal. | As a member of our research community, we would like to invite you to contribute your own research articles to Bladder Cancer, which offers contributing authors many benefits: • First class Editorial Board
• Rigorous peer review and speedy manuscript processing
• Rapid online publication (pre-press) on acceptance
• Articles are currently published open access with no article processing fee Submit your manuscript online via Editorial Manager
View detailed Instructions to Authors
Aims and Scope We look forward to working with you. Best wishes, Editors-in-Chief Seth P. Lerner, MD
Scott Department of Urology
Baylor College of Medicine
Houston, Texas, USA
Email: blc@iospress.com Dan Theodorescu, MD, PhD
Samuel Oschin Comprehensive Cancer Institute
Cedars-Sinai Medical Center
Los Angeles, California, USA
Email: blc@iospress.com | All content is currently freely available online to all readers REVIEW ARTICLE Tumor Subtyping: Making Sense of Heterogeneity with a Goal Toward Treatment
Meeks, Joshua J. | Sjödahl, Gottfrid | Lerner, Seth P. | Das, Arighno | McConkey, David J. | Black, Peter C. RESEARCH ARTICLES The Controlling Nutritional Status (CONUT) Score is a Prognostic Biomarker in Advanced Urothelial Carcinoma Patients Treated with First-Line Platinum-Based Chemotherapy
Suzuki, Hiroaki | Ito, Masaya | Takemura, Kosuke | Kobayashi, Shuichiro | Kataoka, Madoka | Iida, Noriyuki | Sekiya, Ken | Matsumoto, Takuya | Koga, Fumitaka Survival by T Stage for Patients with Localized Bladder Cancer: Implications for Future Screening Trials
Folgosa Cooley, Lauren | Weiner, Adam B. | Meng, Xiaosong | Woldu, Solomon L. | Meeks, Joshua J. | Lotan, Yair Early Bone Metastases are Associated with Worse Outcomes in Metastatic Urothelial Carcinoma
Nelson, Ariel A. | Cronk, Robert J. | Lemke, Emily A. | Szabo, Aniko | Khaki, Ali R. | Diamantopoulos, Leonidas N. | Grivas, Petros | Nezami, Behtash Ghazi | MacLennan, Gregory T. | Zhang, Tian | Hoimes, Christopher J. Well-being and Perceptions of Supportive Resources among Caregivers of Patients with Bladder Cancer
Jung, Ahrang | Song, Lixin | Snyder, Elizabeth | Louwers, Renata K. | Sachse, Karen | Chisolm, Stephanie | Gore, John L. | Smith, Angela B. Evaluating Patient-Defined Priorities for Female Patients with Bladder Cancer
Vo, Amanda X. | Keeter, Mary Kate | Tuchman, Emily S. | Meeks, Joshua J. | Morgans, Alicia K. Comparison of Health-Related Quality of Life Between Japanese and American Patients with Bladder Cancer as Measured by a Newly Developed Japanese Version of the Bladder Cancer Index
Osawa, Takahiro | Wei, John T. | Abe, Takashige | Honda, Michitaka | Rew, Karl T. | Dunn, Rod | Yamada, Shuhei | Furumido, Jun | Kikuchi, Hiroshi | Matsumoto, Ryuji | et al. Prognostic Role of mRNA-Expression of Aquaporins (AQP) 3, 4, 7 and 9 in Stage pT1 Non-Muscle-Invasive Bladder Cancer
Reiß, Julian | Kälble, Sebastian | Bründl, Johannes | Rosenhammer, Bernd | Gierth, Michael | Weber, Florian | Eckstein, Markus | Wirtz, Ralph Markus | Denzinger, Stefan | et al. Surface Labeling with Adhesion Protein FimH Improves Binding of Immunotherapeutic Agent Salmonella Ty21a to the Bladder Epithelium
Burggraaf, Maroeska J. | Waanders, Lisette | Verlaan, Mariska | Maaskant, Janneke | Houben, Diane | Luirink, Joen | Bitter, Wilbert | Kuijl, Coen | Molthoff, Carla F.M. Bladder Cancer Health Literacy: Assessing Readability of Online Patient Education Materials)
Powell, Lauren E. | Cisu, Theodore I. | Klausner, Adam P. OTHER CONTENT Challenging Cases in Urothelial Cancer: Case 19
Soloway, Mark S. | Abrahams, Neil A. Clinical Trials Corner Issue 7(1)
Agarwal, Piyush K. | Sternberg, Cora N. Paper Alert: BCG versus Cystectomy for High Risk, High Grade Non Muscle Invasive Bladder Cancer
Messing, Edward M. | | New Associate Editor for Reviews: Andrea Apolo, MD | We are pleased to announce that Andrea Apolo, MD, has been promoted to Associate Editor for Reviews for Bladder Cancer as of March 2021. Dr. Apolo works within the Center for Cancer Research of the National Cancer Institute as Head of the Bladder Cancer Section of the Genitourinary Malignancies Branch and Director of the Bladder Cancer and Genitourinary Tumors Multidisciplinary Clinic. She has been instrumental in the clinical development of multiple immunotherapeutic agents and immunotherapeutic combinations, from first-in-human studies through phase 3 clinical trials. She leads multiple rationally designed, cutting-edge targeted therapy and immunotherapy combination studies in bladder cancer and rare genitourinary tumors. Editor-in-Chief Dan Theodorescu comments: "It is a pleasure to welcome Andrea Apolo, MD, to her new role as Associate Editor for Reviews, alongside Georgios Gakis, MD, PhD, and Nathan Lawrentschuk, MD, PhD. I have known Andrea since her days as a GU medical oncology fellow and have always been impressed by her passion, work ethic and accomplishments. The journal is very lucky to have attracted her in this capacity and we look forward to her sage advice to propel us to even higher service and impact for the bladder cancer community. At the same time, we give heartfelt thanks to Matthew Galsky, MD, who is stepping down from this position to focus on this new role as Division Head of Medical Oncology at Mount Sinai in New York. We thank Matt for his many contributions to the journal and will miss him while wishing him all the best in his new role." | Finding A Clinical Trial The Bladder Cancer Advocacy Network (BCAN) maintains an up-to-date and comprehensive database of bladder cancer clinical trials, along with information for anyone who is interested to participate in a trial. Discover more at: ▪ Find a trial
▪ About trials
In the most recent BCAN newsletter, there is an honest and passionate article that shares the story of one patient and their experience with clinical trials, with input from David Y.T. Chen, MD, FACS, professor in the Department of Surgical Oncology at Fox Chase Cancer Center in Philadelphia. View the article via the BCAN website (Fall 2020 newsletter). Save the Date: BCAN Think Tank is planned as an in-person event in August 2021 in Denver | Listing articles published only in 2019 & 2020 so you can read the most popular recent content In the World of Bladder Tumors: Size Does Matter (Research Article in Vol.6, Iss.2, 2020)
Loloi, Justin | Allen, Jordan L. | Schilling, Amber | Hollenbeak, Christopher | Merrill, Suzanne B. | Kaag, Matthew G. | Raman, Jay D. FGFR3 – a Central Player in Bladder Cancer Pathogenesis? (Review Article in Vol.6, Iss.4, 2020)
Knowles, Margaret A. Histologic Variants of Urothelial Carcinoma: Morphology, Molecular Features and Clinical Implications (Review Article in Vol.6, Iss.2, 2020)
Alderson, Meera | Grivas, Petros | Milowsky, Matthew I. | Wobker, Sara E. Clinical Development of FGFR3 Inhibitors for the Treatment of Urothelial Cancer (Review Article in Vol.5, Iss.2, 2019)
Ibrahim, Tony | Gizzi, Marco | Bahleda, Ratislav | Loriot, Yohann Cisplatin Ineligibility for Patients With Metastatic Urothelial Carcinoma: A Survey of Clinical Practice Perspectives Among US Oncologists (Research Article in Vol.5, Iss.4, 2019)
Galsky, Matthew D. | Ma, Esprit | Shah-Manek, Bijal | Mills, Rosalina | Ha, Long | Krebsbach, Craig | Blouin, Eric | Tayama, Darren | Ogale, Sarika | Help Spread the News of BLC! | If you know of any colleagues or fellow researchers who are not yet signed up to receive the newsletter, we invite you to share this mailing with them. Click on the visual or access the sign-up link here. BLC has an active social media presence. If you are not yet interacting with the journal on social media, why not take the time today to follow us on Twitter? Be part of the discussion! | You are receiving this mailing as you are signed up to receive news from BLC.
You can unsubscibe or alter your preferences at any time by clicking the links below. | |
